James Aaron Balog,Steven P. Seitz,Susheel Jethanand Nara,Saumya Roy,Srinivasan Thangathirupathy,Soodamani Thangavel,Srinivas Cheruku
申请号：
US16555431
公开号：
US20200069695A1
申请日:
2019.08.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the disclosure.
